235 related articles for article (PubMed ID: 34639614)
1. Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting.
Kaambwa B; Bulamu NB; Mpundu-Kaambwa C; Oppong R
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639614
[TBL] [Abstract][Full Text] [Related]
2. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
[TBL] [Abstract][Full Text] [Related]
3. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
4. An empirical comparison of the OPQoL-Brief, EQ-5D-3 L and ASCOT in a community dwelling population of older people.
Kaambwa B; Gill L; McCaffrey N; Lancsar E; Cameron ID; Crotty M; Gray L; Ratcliffe J
Health Qual Life Outcomes; 2015 Sep; 13():164. PubMed ID: 26420314
[TBL] [Abstract][Full Text] [Related]
5. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
Khanna R; Jariwala K; Bentley JP
Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
[TBL] [Abstract][Full Text] [Related]
7. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
8. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
Zare F; Ameri H; Madadizadeh F; Aghaei MR
Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
[TBL] [Abstract][Full Text] [Related]
11. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
12. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
[TBL] [Abstract][Full Text] [Related]
13. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
[TBL] [Abstract][Full Text] [Related]
14. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
[TBL] [Abstract][Full Text] [Related]
15. Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population.
Shafie AA; Chhabra IK; Hui Yi JW; Mohammed NS; Ibrahim HM
Value Health Reg Issues; 2021 May; 24():47-56. PubMed ID: 33508751
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
[TBL] [Abstract][Full Text] [Related]
17. Convergent validity of the EQ-5D-3L in a randomized-controlled trial of the Housing First model.
Kozloff N; Pinto AD; Stergiopoulos V; Hwang SW; O'Campo P; Bayoumi AM
BMC Health Serv Res; 2019 Jul; 19(1):482. PubMed ID: 31300051
[TBL] [Abstract][Full Text] [Related]
18. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.
Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J
Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789
[TBL] [Abstract][Full Text] [Related]
19. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
[TBL] [Abstract][Full Text] [Related]
20. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
